Apyx Medical Corporation APYX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Net margin | -21%+27.9pp | -48.9%-13.1pp | -35.7%+16.3pp | -52.1%-20.8pp | |
| Returns | |||||
| Return on equity | -77.3%+37.7pp | -115%-56.7pp | -58.2%-7.4pp | -50.8%-25.0pp | |
| Efficiency | |||||
| Asset turnover | 0.8×+0.1× | 0.7×-0.1× | 0.8×+0.1× | 0.7×+0.1× | |
| Liquidity | |||||
| Current ratio | 5×-0.3× | 5.3×-0.3× | 5.5×+1.9× | 3.6×-1.0× | |
| Leverage | |||||
| Debt-to-equity | 2.7×0.0× | 2.7×+1.3× | 1.4×+1.4× | 0×0.0× | |
| Valuation | |||||
| Market capitalization | $181.07M+114% | $59.48M-34.5% | $90.77M+12.1% | $80.96M-81.7% | |
| Price / sales | 3.2×+1.4× | 1.2×-0.5× | 1.7×-0.1× | 1.8×-7.3× | |
| Price / book | 14.1×+2.4× | 4.2×+0.8× | 3.4×+1.2× | 2.2×-6.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Apyx Medical Corporation's profit margins?
- Apyx Medical Corporation (APYX) runs a 61.9% gross margin and a -46.0% operating margin, with a -16.2% net margin.
- Where do Apyx Medical Corporation's ratios come from?
- Every ratio is computed from Apyx Medical Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
